Article2011

Differences in costs of and access to pharmaceutical products in the EU

Panos G. Kanavos · Sotiris Vandoros · Rachel Irwin · Elena Nicod · Margaret Casson

89 citations0/0 files stored

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Healthcare Systems and Reforms Health Systems, Economic Evaluations, Quality of Life

Abstract

This report reviews the differences in the prices of pharmaceuticals among Member States. It presents an overview of the prices for pharmaceuticals protected by patents as well as those for off-patent pharmaceuticals subject to competition from lower-priced “generic” versions. The report reviews the approaches that Member States have used to regulate the pharmaceutical market on both the supply and demand sides, and assesses evidence regarding the impact of these different approaches on pharmaceutical prices, costcontainment, industry innovation. The report also considers the implications for patient access to pharmaceuticals. The report considers policy options to strengthen coordination among Member States and exchange best practice.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 89 citations exist upstream.

Cited by

2015Causes of drug shortages in the legal pharmaceutical framework 2011Underuse of generic medicines in Portugal: An empirical study on the perceptions and attitudes of patients and pharmacists 2014Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries

Imported from OpenAlex (CC0) — nothing here is generated.